In The Mycota XI Edited by: KempkenF edited by Berlin, Germany: Springer Verlag. 2002, 341–358. 71. Lagaert S, Belien T, Volckaert G: Plant cell walls: Protecting the barrier from degradation by microbial enzymes. Semin Cell Dev Biol 2009, 20:1064–1073.PubMedCrossRef 72. Alghisi P, Favaron F: Pectin-degrading enzymes and plant-parasite interactions. Eur J Plant Pathol 1995, 101:365–375.CrossRef 73. Maulik A, Ghosh H, Basu S: Comparative study of protein-protein interaction observed in Polygalacturonase-inhibiting proteins from Phaseolus vulgaris and Glycine max and Polygalacturonase from Fusarium moniliforme . BMC Genomics

2009, 10:S19.PubMedCrossRef 74. King BC, Waxman KD, Nenni Small molecule library high throughput NV, Walker LP, selleck chemical Bergstrom GC, Gibson DM: Arsenal of plant cell wall degrading enzymes reflects host preference among plant pathogenic fungi. Biotechnol Biofuels 2011, 4:4.PubMedCrossRef 75. Dodds PN: Genome Evolution in Plant Pathogens. Science 2010, 330:1486–1487.PubMedCrossRef 76. Baxter L, Tripathy S, Ishaque N, Boot N, Cabral A, Kemen E, Thines M, Ah-Fong A, Anderson R, Badejoko W, et al.: Signatures of adaptation to obligate biotrophy in the Hyaloperonospora arabidopsidis genome. Science 2010, 330:1549–1551.PubMedCrossRef 77. Huson D, Richter D, Rausch C, Dezulian T, Franz M, Rupp R: Dendroscope: An interactive

viewer for large phylogenetic trees. BMC Bioinformatics 2007, 8:460.PubMedCrossRef ��-Nicotinamide mw Authors’ contributions ALM, MGZP and UCS carried out the experiments. ALM and NCC carried out data analysis. ALM, MGZP and HCC conceived and designed the study, guided data analysis, interpretation, and discussion, and wrote the manuscript with comments from ELR and RLG. ELR participate in biochemical interpretation of data and RLG participate in genomic library construction. All authors read and approved the final manuscript.”
“Background

Avelestat (AZD9668) Acidithiobacillus ferrooxidans is an acidophilic, chemolithoautotrophic bacterium that derives energy from the oxidation of ferrous iron, elemental sulfur and reduced sulfur compounds [1]. This bacterium has been successfully used in bioleaching to recover metals from low-grade sulfide ores. During the bioleaching process, A. ferrooxidans is subjected to extreme growth conditions, such as temperature increase, pH fluctuations, nutrient starvation, and the presence of heavy metals [2], all of which can affect the efficiency of metal recovery. Temperature change is one of the most common environmental stresses that can influence essential bacterial processes such as energy transduction and growth. All organisms tend to respond to environmental stresses with a rapid transient increase in heat shock protein (HSP) synthesis. HSPs act either as molecular chaperones, mediating the correct folding and assembly of proteins, or as proteases, irreversibly degrading unfolded proteins [3].

Thus all mutants were generated from V. parahaemolyticus VP53. Unless otherwise stated, bacteria were cultured in Vactosertib datasheet LB broth or LB agar at 37°C. Antibiotics

were added in the following concentration when needed: chloramphenicol at 10 μg/ml, and Kanamycin at 50 μg/ml for Escherichia coli and 100 μg/ml for V. parahaemolyticus. To induce rugose phenotype, a single colony was inoculated into 2 ml APW#3 broth [22], incubated at 37°C statically for 48 hours. Then 1 μl of culture was spotted on LB agar plate and incubated at 30°C for 48-72 hours. Pictures were taken when colony size reached Selleck Smoothened Agonist about half centimeter. Construction of Mutants Genetic regions to be targeted and primer sequences were determined based on the annotation of V. parahaemolyticus genome RIMD2210633 (GenBank Accession BA000031 and BA000032). Selleck RAD001 Several mutants, including a mutation deleting the entire K-antigen structural gene operon on chromosome I (VP0219-0237), several partial deletion mutations in the region on chromosome I (VP0215-0218 and VP0220 gene), and a deletion mutation of exopolysaccharide region in chromosome

II (VPA1403-1406) as well as a deletion mutation in a separate region containing polysaccharide transport genes wza, wzb, and wzc were constructed (Table 1). Polymerase Chain Reaction (PCR) was performed using Taq DNA polymerase (Thermo Fisher, Waltham, MA). PCR products were purified on Qiagen PCR purification columns (Qiagen, Valencia, CA). Restriction enzymes were purchased Histidine ammonia-lyase from New England Biolabs (Ipswich, MA). DNA was prepared for crossover recombination by overlapping PCR. First, three DNA fragments were amplified by PCR separately, including a fragment (500-1000 bp) upstream of targeted gene in V. parahaemolyticus, a fragment

(500-1000 bp) downstream of targeted gene in V. parahaemolyticus and a chloramphenicol resistant gene (Cm) in pKD3 [31]. The 3′ end of the reverse primer in the upstream DNA was complementary to the forward primer of Cm, and the 5′ end of the forward primer of downstream DNA was complementary to the reverse primer of Cm. Then the three fragments were mixed and assembled into one piece in a second PCR reaction where the product was amplified by primers at the two extremes. Genes deleted and primers used are listed in (Table 3). Two to four micrograms of PCR product were used to transform V. parahaemolyticus VP53.

Photos were analysed with CellSens Dimension Desktop version 1.3 (Olympus Corporation). The level of angiogenesis in eight CAM tissues from each group was determined by calculating the vessel area, length and number of branch points on three square areas of dimensions 2.5 × 2.5 mm (total area, 18.75 mm2 out of 78.5 mm2). CAM tissue areas were selected semi-randomly so that the vessels MDV3100 with a diameter greater than 200 μm were not assessed. Vessel area, length and number of branch points were calculated separately for vessels with a diameter smaller than 100 μm and those between 100 and 200 μm. To calculate the vessel area, the intensity differences between vessels

and background were increased. Local contrast of images was strengthened by increasing the intensity by 20 and brightness by 300 (kernel radius, 128). The threshold was set at intensity volumes between 0 and 256 for shades of red, 0 and 256 for green, and 0 and 145 for blue (Figure 2). Figure 2 CAM assay for determining total area of vessels with CellSens Dimension Desktop version 1.3. (A) CAM square area of dimensions 2.5 × 2.5 mm and (B) image with a strengthened local contrast of images by increasing intensity and brightness. (C) For total area calculation, the threshold was set at intensity volumes between 0 and 256 for the shades of red, 0 and 256 for green, 0 and 145 and for blue. CAM tissue morphological analysis CAM implant morphology

and development of capillary Integrase inhibitor vessels were determined with the stereomicroscope described above. CAM cross sections were made with a cryostat (CM 1900, Leica, Wetzlar, Germany). Blocks were cut into 5-μm-thick sections and observed under selleck chemical a light microscope (DM 750, Leica). Immunoblotting Protein levels of CAM KDR and FGFR were examined by Western blot analysis. Protein extracts were prepared with TissueLyser LT (Qiagen, Hilden, Germany) using ice-cold RIPA buffer (150 mM NaCl, 0.5% sodium deoxycholate, 1% NP-40, 0.1% SDS, 50 mM Tris, pH 7.4) with Cell Cycle inhibitor protease and phosphatase inhibitors (Sigma). The protein concentration was determined by the Total Protein Kit, Micro

Lowry, Peterson’s Modification (Sigma). An equal volume (50 mg) of samples was denatured by the addition of sample buffer (Bio-Rad Laboratories, Munich, Germany) and boiled for 4 min. Proteins were resolved under reductive conditions with SDS-PAGE and transferred onto PVDF membrane (Life Technologies, Gaithersburg, MD, USA). Protein bands were visualised with the GelDoc scanner (Bio-Rad Laboratories), using the fluorescent method of the WesternDot Kit (Life Technologies) and the primary antibodies bGFR (cat. no. F4305-08, USBiological, Swampscott, MA, USA), KDR (cat. no. SAB4300356, Sigma) and GAPDH (cat. no. NB300-327, Novus Biologicals, Cambridge, UK) as loading control (dilutions recommended by the producers). Protein bands were characterised using the Quantity One 1-D analysis software (Bio-Rad Laboratories).

A large number of phase 2 and 3 clinical trials have been carried out, including more than 8,000 patients on strontium ranelate with nearly 36,000 patient-years of exposure

[6]. A recent pooled analysis in 7,572 postmenopausal women (3,803 strontium ranelate and 3,769 placebo) indicated an increased risk for myocardial infarction (MI) with strontium ranelate, with estimated annual incidences of 5.7 cases per 1,000 patient-years versus 3.6 cases per 1,000 patient-years with placebo [6]. This translates into an odds ratio (OR) for MI of 1.60 (95 % confidence interval [CI], 1.07–2.38) for strontium ranelate versus placebo (incidences of 1.7 % versus selleck 1.1 %, respectively) [6]. Among the cases of MI, fatal events were less frequent with strontium

ranelate (15.6 %) than with placebo (22.5 %). In order to reduce the risk in treated patients in routine clinical practice, new contraindications have been proposed for strontium ranelate in patients with a history of cardiovascular disease (history of ischaemic heart disease, peripheral artery disease, and cerebrovascular disease, and uncontrolled hypertension) [7]. Exclusion of patients with these contraindications from the pooled analysis mitigated the risk for MI (OR, 0.99; 95 % CI, 0.48–2.04; data on file). There has been no suggestion of excessive cardiac events in postmarketing surveillance data for strontium ranelate covering more than 3.4 million patient-years of treatment from September 2004 to selleck kinase inhibitor February 2013. There have been 16 cases of MI spontaneously reported over the 96-month period of monitoring, i.e. a rate of 0.5 cases per 100,000 patient-years [6]. Similarly, an observational prospective cohort study including 12,076 patients on strontium ranelate with 80 % adherence over 2 years did not support increased incidence of cardiac events over the 32.0 ± 9.7 months of

follow-up; there were 33 cases of MI in the cohort (1.3 per 1,000 patient-years) [6, 8]. In this paper, we describe a nested case–control study performed within the UK Clinical Practice Research Datalink (CPRD) apparatus to further explore the risk for ischaemic cardiac events associated with the use of strontium ranelate in routine clinical practice in women with postmenopausal osteoporosis. very Methods Study population The main data source for this nested case–control study was the CPRD, which comprises anonymous electronic medical records from primary care in the UK and covers about 8 % of the population. Contributing CPRD physicians come from some 640 practices throughout the UK, which must meet specific up-to-standard (UTS) reporting requirements defined by the CPRD. The accuracy and completeness of the CPRD dataset has been confirmed [9, 10], as has the predictive value of the Torin 1 cost database for cardiac events, including MI [11, 12]. The positive predictive value of the CPRD to detect acute MI, for example, is 93 % (95 % CI, 90–96 %), i.e.

Analysis of defensin expression by human primary airway epithelial cells exposed to A. fumigatus conidia or hyphal fragments To provide evidence selleck inhibitor for the biological significance of the discovered phenomenon, we verified whether or not

inducible defensin expression was Selleck Idasanutlin observed in the human primary airway epithelial cells, in addition to the detected defensin expression in airway cell lines A549 and 16HBE (described above). Airway epithelial cells obtained from human nasal turbinates (HNT) of patients undergoing turbinectomy were exposed to RC, SC or HF or latex beads for 18 hours. Examination of hBD2 or hBD9 expression showed that both defensins were detected by RT-PCR in the primary culture cells exposed to all of the morphotypes of A. fumigatus (Figure 5). The relative level of hBD2 and hBD9 expression in HNT cells was quantified by real time PCR. The expression of both defensins was higher in Il-1β stimulated cells than in the control, as shown in Figure 6. Exposure of HNT cells to SC resulted in a statistically significant increase of hBD2 and hBD9 expression compared BAY 63-2521 nmr to that of the untreated control cells or the cells exposed to the latex beads. The increase of defensin expression was also found in the cells exposed to RC and HF. However,

this difference was significant only for hBD2 in the cells exposed to RC. The difference in expression of hBD9 by the cells exposed to RC and in the expression of hBD2 as well as hBD9 by the cells exposed to HF did not reach a significant level. There was no difference between defensin expression in the untreated control cells and

the cells exposed to the latex beads. Figure 5 RT-PCR analysis of defensin mRNA expression by primary epithelial cells. Primary epithelial cells were obtained from human nasal turbinates Dichloromethane dehalogenase (HNT), as described in Methods. The cells (5 × 106) were grown in the six well plates for 48 hours. The cells were then exposed to either the latex beads or A. fumigatus organisms for 18 hours. The mRNA was then isolated by TRIzol Reagent and RT-PCR was performed as described above in Materials and Methods. Specific primer pairs (Table 1) were used for RNA amplification. The sizes of amplified products are indicated and were as predicted. The hBD2 and hBD9 products were sequenced and confirmed to be identical to the predicted sequence. GAPDH was uniformly expressed. Cells in a control well were cultivated in the absence of A. fumigatus. One of the three results is shown. Figure 6 Analysis of mRNA levels for HBD2 and HBD9 in HNT primary culture cells exposed to A. fumigatus organisms. Primary epithelial HNT cells (5 × 106) were grown in six well plates for 48 hours. The cells were then exposed to the different morphotypes of A. fumigatus or latex beads for 18 h. Cells were cultivated in a control well in the absence of A. fumigatus or the latex beads. Isolation of total RNA and synthesis of cDNA was performed as described in Methods.

55; 95% CI 1.11-2.17; P = 0.01) was more frequent in patients with HCC than the CC or CT variants, but the frequency of the CC genotype was not significantly different between HCC and healthy donors (P = 0.249); at rs3761549, the CC genotype (OR 1.92; 95% CI 1.39-2.64; P < 0.001) was more frequent in patients find more with HCC than the TT or CT variants, but the frequency of the TT genotype was not significantly different between HCC and healthy donors (P = 0.118). Compared to HCC patients, the CT genotype at both rs2280883 and Selleck DMXAA rs3761549 was significantly more frequent in healthy donors than the CC or TT variants (both P < 0.001) (Table 3 and Additional file 1: Table S1). For CHB donors and healthy donors, the CT genotype at rs2280883 was

more frequent in healthy donors than the CC or TT variants (P = 0.004), but there were no significant differences in the distribution of either CC or TT genotypes between CHB donors and healthy donors (P = 0.051, P = 0.479); at rs3761549, the CC genotype (OR 1.63; 95% CI 1.18-2.25; P = 0.003) was more frequent in patients with CHB than the TT or CT variants, but there was no significant difference in the distribution of the TT genotype between CHB donors and healthy donors (P = 0.198). The selleck products CT genotype was more frequent in healthy donors than the CC and TT variants (P < 0.001) (Table 3 and Additional file 1: Table S1). However, there were no significant

differences in the FOXP3 Carnitine palmitoyltransferase II genotype distribution between HCC donors and CHB donors at either rs2280883 or rs3761549 (Table 3 and Additional file 1: Table S1). Compared to healthy donors, the TT genotype at rs2280883 was more frequent in patients with HCC, but this genotype frequency was not significantly different between CHB and healthy donors, in addition, the CC

genotype at rs2280883 was more frequent in CHB patients (16.0%) than in HCC patients (13.8%), but the TT genotype was more frequent in HCC patients (79.6%) than in CHB patients (74.1%); these results showed that the TT genotype at rs2280883 was associated with HCC but not with CHB. The stratified analysis of the association between FOXP3 genotypes and HCC clinical pathology variables Because the FOXP3 genetic variants rs2280883 and rs3761549 were significantly associated with susceptibility to HCC, further analysis was performed to determine the relationship between the FOXP3 genotype and multiple HCC clinical pathology variables, such as age, gender, alcohol abuse history, tumor size, tumor nodule, tumor grade, lymph node metastasis, portal vein tumor thrombus, distant metastasis and recurrence. Follow-up records had not been completed for all of the patients, and detailed clinical pathology variables were available for only 188 cases; these details are shown in Table 4. The CC genotype of rs3761549 was more frequent in HCC patients with portal vein tumor thrombus (P = 0.02), and the TT and CT genotypes were more common in patients with recurrent HCC (P = 0.001).

Open questions were used to gather information about the startup process and how the upscaling process went so far. Generally, the initial portion of the interviews focused on the history of the enterprise, along with the challenges faced

till today. The later part of the interview was focused on questions informed by Table 1. Interviews generally lasted for around one and half hours to two hours, depending upon the availability of the interviewees. D.light Design could not be contacted for direct interview and most information exchange took place through email. Finally, selleck chemicals llc site visits of the social enterprises added insights about how they were really functioning. We obtained secondary information through the organizations’ selleckchem websites, presentations

in seminars, financial reports, business plans, market analyses, and research documents prepared by the people working in the organizations. In addition, we relied on case studies prepared by other researchers on the organizations, accounts in the published literature, interviews of the entrepreneurs in newspapers and web articles, etc. Results In this section, the case study results are presented. The details of the cases are presented in Table 3. Table 3 Details of the case studies Case SELCO AuroRE THRIVE NEST Solar D.light Design Founders Dr. Harish Hande and Neville William Hemant Lamba Dr. Ranganayakulu

Bodavala D.T. Barki Sam Goldman and Ned Tozun Founding year 1995 1998 2001 1998 2007 Location Bangalore Auroville, Puducherry Hyderabad Hyderabad New Delhi Vision “Empowering the lives of underserved populations by buy KU55933 creating linkages between income generation and sustainable energy services” “Establishing a platform for renewable energy by integrating service providers, users, manufacturers, financers and policy makers” “Provide clean and reliable lighting solutions to billions of people around the world, improving the living conditions of people” “Eliminating light poverty from the learn more world by providing innovative lighting solutions to the poor” “Enable households without reliable electricity to attain the same quality of life as those with electricity and replacing kerosene with clean, safe and bright solar light” Type of organization For-profit social enterprise Non-profit organization, community-based organization NGO with separate commercial enterprise For-profit enterprise Commercial social for-profit enterprise Profitability Almost break-even stage, i.e.

CrossRef 15. Iwasaki H, Mizokawa Y, Nishitani R, Nakamura S: X-ray photoemission study of the initial RG-7388 in vivo oxidation of the cleaved (110) surfaces of GaAs, GaP and InSb. Surf Sci 1979, 86:811–818.CrossRef 16. Legare P, Hilaire L, Maire G: The superficial oxidation of indium,

Sb and InSb(111) – a LEED, AES, XPS and UPS study. J Microsc Spectrosc Electron 1980, 5:771–782. 17. Tang X, Weltenis RGV, Setten FMV, Bosch AJ: Oxidation of the InSb surface at room temperature. Semicond Sci Technol 1986, 1:355–365.CrossRef 18. Barr TL, Ying M, Varma SJ: Detailed X-ray photoelectron-spectroscopy valence band and core level studies of select metals oxidations. Vac Sci Technol A 1992, 10:2383–2390.CrossRef 19. Ohshita M: High electron mobility InSb films prepared by source-temperature-programed evaporation method. Jpn J Appl Phys 1971, 10:1365–1371.CrossRef 20. Jin YJ, Zhang DH, Chen XZ, Tang XH: Sb antisite check details defects in InSb epilayers prepared by metalorganic chemical vapor deposition. J Cryst Growth 2011, 318:356–359.CrossRef 21. Vishwakarma SR, Verma AK, Tripathi RSN, Das S, Rahul: Study of structural property of n-type indium antimonide thin films. Indian J Pure and Appl Phys 2012, 50:339–346. 22. Rahul, Vishwakarma SR, Verma AK, Tripathi RSN: Energy band gap and conductivity measurement of InSb thin films deposited by electron

beam evaporation technique. M J Condensed Matter 2010, 13:34–37. 23. Lim T, Lee S, Meyyappan M, Ju S: new Tin oxide and indium oxide nanowire transport characteristics: influence of oxygen concentration during synthesis. Semicond Sci Technol 2012, 27:035018.CrossRef 24. Xie X, Kwok SY, Lu Z, Liu Y, Cao Y, Luo L, Zapien JA, Bello I, Lee CS, Lee ST, Zhang W: Visible–NIR photodetectors based on CdTe nanoribbons. Nanoscale 2012, 4:2914–2919.CrossRef 25. Chang WC, Kuo CH, Lee PJ, Chueh YL, Lin SJ: Synthesis of single crystal Sn-doped In2O3 nanowires: size-dependent conductive characteristics. Phys Chem Chem Phys 2012, 14:13041–13045.CrossRef 26. Stern E, Cheng G, Cimpoiasu E, Klie

R, Guthrie S, Klemic J, Kretzschma I, Steinlauf E, Turner-Evans D, Broomfield E, Hyland J, Koudelka R, Boone T, Young M, Sanders A, Munden R, Lee T, Routenberg D, Reed MA: Electrical characterization of single GaN nanowires. Nanotechnology 2005, 16:2941–2953.CrossRef 27. Chen KK, Furdyna JK: Temperature dependence of intrinsic carrier concentration in InSb: direct determination by helicon interferometry. J Appl Phys 1825, 1972:43. 28. Reisfeld R: Nanosized semiconductor particles in glasses prepared by the sol–gel method: their optical properties and potential uses. J Alloys Compd 2002, 341:56–61.CrossRef 29. Burstein E: Anoma1ous optical absorption limit in InSb. Phys Rev 1954, 93:632.CrossRef 30. Sakai K, Kakeno T, Ikari T, Shirakata S, Sakemi T, Awai K, Yamomoto T: Defect centers and optical absorption edge of degenerated semiconductor ZnO thin films grown by a reactive plasma deposition by means of piezoelectric photothermal spectroscopy.

Dated records are important as scientists attempt to document range shifts; Selleckchem 17-AAG e.g. tapir, Sumatran rhinoceros and orangutans were more widely distributed until recently (Meijaard 2003; Tougard and Montuire 2006; Earl of Cranbrook 2009). Some of the impediments to developing regional public databases for conservation managers are discussed by Srikwan et al. (2006) and Webb et al. (2010). Patterns of distribution There are many biogeographic patterns within Southeast Asia including temperate—tropical gradients in species richness, a peninsula effect at the tip of the Thai-Malay peninsula, and numerous examples of the species-area effect. The latter

are important to conservationists as the rise in sea level (discussed

below) will result in more species losses on smaller islands (Okie and Brown 2009). Other patterns of interest include the location of biodiversity hotspots, centers of endemism and refugia. Although defining hotspots as congruent with whole biogeographic subregions (Fig. 1: Indochina, Sundaic, Philippine and Wallacea), as done by Conservation International (2007), may be too broad-scale for some purposes, the identification of smaller areas of endemism or species richness can guide the location of protected areas, e.g., the Mentawi islands with their Selleck NU7441 17 species of endemic mammals (Corlett 2009a), numerous isolated karst mountains (Clements et al. 2006, 2008), IUCN’s Key Biodiversity Areas (Brooks et al. 2008), and BirdLife International’s Important Bird Areas (Chan et al. 2004). Understanding the history of today’s hotspots is necessary to establish whether they are ancient and geographically fixed, or whether they have moved in response to past climatic change? Hotspots of freshwater biota are

also known: the mid- and lower-Mekong River has probably the second richest fish fauna in the world (Rainboth et al. 2010) and also harbors a very diverse mollusc fauna. Unfortunately, both the basic documentation of this fauna and the still confused history of the region’s rivers make it difficult to delimit aquatic hotspots. Although terrestrial Etoposide biotas may be conserved by protecting hotspots (fortress conservation) this approach is less useful for river and wetland biotas whose conservation typically requires watershed level management. If hotspots capture areas of great species richness today, Pleistocene refugia are thought to have enabled these species to survive environmental challenges in the past. Several workers have argued that during cooler glacial conditions rainforest retreated to the hills of peninsula Malaysia, western Sumatra, the Mentawi Islands, and the center of Borneo, and that during hypothermal periods the rainforest was replaced by savanna woodland or grassland on the emerged Sunda plains and elsewhere (Heaney 1991; Morley 2000, 2007).

PubMedCrossRef 13. Hoyo I, Martínez-Pastor J, Garcia-Ramiro S, et al. Decreased serum linezolid concentrations in two patients receiving linezolid and rifampicin due to bone infections. Scand J Infect Dis. 2012;44:548–50.PubMedCrossRef 14. Tornero E, selleck inhibitor García-Oltra E, García-Ramiro S, et al. Prosthetic joint infections due to Staphylococcus aureus and coagulase-negative staphylococci. Int J Artif Organs. 2012;35:884–92.PubMed 15. Bassetti M, Vitale F, Melica G, et al. Linezolid in the treatment of Gram-positive prosthetic

joint infections. J Antimicrob Chemother. 2005;55:387–90.PubMedCrossRef 16. Rao N, Hamilton CW. Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series. Diagn Microbiol Infect Dis. 2007;59:173–9.PubMedCrossRef 17. Bradbury T, Fehring TK, Taunton M, et al. The fate of acute methicillin-resistant Staphylococcus aureus periprosthetic knee infections treated by open debridement and retention of components. J Arthroplasty. 2009;24:101–4.PubMedCrossRef 18. Legout L, Valette M, Dezeque H, et al. Tolerability of prolonged linezolid therapy in bone and joint infection: protective effect of rifampicin on the occurrence buy LY3023414 of anaemia? J Antimicrob

Chemother. 2010;65:2224–30.PubMedCrossRef 19. Soriano A, Gómez J, Gómez L, et al. Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections. Eur J Clin Microbiol Infect Dis. 2007;26:353–6.PubMedCrossRef 20. Zimmerli W, Frei R, Widmer AF, Rajacic Z. Microbiological tests to predict treatment outcome in experimental device-related

infections due to Staphylococcus aureus. J Antimicrob Chemother. 1994;33:959–67.PubMedCrossRef 21. Nguyen S, Pasquet A, Legout L, et al. Efficacy and tolerance of rifampicin-linezolid compared with rifampicin-cotrimoxazole combinations in prolonged oral therapy for bone and joint infections. Clin Microbiol Infect. 2009;15:1163–9.PubMedCrossRef 22. Gómez J, Canovas E, Baños V, et al. Linezolid plus rifampin as a salvage therapy in prosthetic joint infections treated without removing the implant. Antimicrob Agents Chemother. 2011;55:4308–10.PubMedCentralPubMedCrossRef 23. Brandt CM, Sistrunk WW, Duffy MC, et al. Staphylococcus aureus prosthetic O-methylated flavonoid joint infection treated with debridement and prosthesis retention. Clin Infect Dis. 1997;24:914–9.PubMedCrossRef 24. Craig WA. Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid. Infect Dis Clin North Am. 2003;17:479–501.PubMedCrossRef 25. Jones RN, Kohno S, Ono Y, Ross JE, Yanagihara K. ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countries. Diagn Microbiol Infect Dis. 2009;64:191–201.PubMedCrossRef 26. Cattaneo D, Orlando G, Cozzi V, et al. Linezolid plasma concentrations and occurrence of drug-related hematological toxicity in patients with Gram-positive infections.